Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Comparison of PPI Versus no PPI on Top of Standard Dose Clopidogrel Therapy in Patients Stratified Based on CYC2C19 Activity Via a Genetic Point of Care System.

NCT01512953 is registered in ClinicalTrials.gov with Università degli Studi di Ferrara as lead sponsor.

NCT NCT01512953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01512953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Comparison of PPI Versus no PPI on Top of Standard Dose Clopidogrel Therapy in Patients Stratified Based on CYC2C19 Activity Via a Genetic Point of Care System.
Lead sponsor
Università degli Studi di Ferrara
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2011
Completion date
August 31, 2013
Enrollment
522 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary stenting